Clinical Trial Update: Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes [Phase 2]

View source ↗

Summary

This Phase 2 trial compared the bioavailability of inhaled Technosphere Insulin with subcutaneous regular human insulin in adults with Type 2 diabetes mellitus,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Regular human insulin (human insulin (regular))
• Technosphere insulin (insulin inhalation)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED